Saphetor provides bioinformatics solutions for analyzing and interpreting large-scale Next-Generation Sequencing (NGS) data in genomics. Its flagship VarSome Suite includes VarSome.com, a free community-driven platform, plus premium extensions VarSome Premium and VarSome Clinical. VarSome Premium adds extra third-party annotation data and features for subscribers, while VarSome Clinical is CE IVD certified and HIPAA compliant for professional use by researchers and clinicians. The company earns revenue through subscriptions and premium features. Saphetor differentiates itself by combining a widely used community platform with clinical-grade tools that support precision medicine, backed by a large global user base and collaborations with over 2,000 organizations. Its goal is to enable accurate genome interpretation and support researchers and clinicians in making informed decisions in precision medicine.
Company Size
51-200
Company Stage
Series A
Total Funding
$5.9M
Headquarters
Lausanne, Switzerland
Founded
2014
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?